Price $4.52 |
Market Cap
9.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.04
|
P/S
0.54
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-19.8K
|
FCF
-25.7
|
|
Op. Margin
-310.30%
|
Net Margin
-324.70%
|
ROE
-310.70%
|
ROI
-63.90%
|
|
ROA
-93.30%
|
EPS Growth
8.10%
|
Current Ratio
2.7
|
Debt/Equity
87.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Avalo Therapeutics Inc (AVTX) | $4.03 | - | - | 47.6M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.20 | - | - | 10.35B | Strong Buy |
| Clover Health Investments Corp (CLOV) | $1.20 | - | - | 443.2M | Strong Buy |
| Precision BioSciences Inc (DTIL) | $1.16 | - | - | 112.1M | Strong Buy |
| Codexis, Inc. (CDXS) | $6.48 | - | - | 307.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
